Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,685,774
-$2,146,884 QoQ
Shares Held
339,113
-59.3% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#54
of 238 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $109,740,543 across 18 Drug Manufacturers - Specialty & Generic names. XERS ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
676,544 | $48,616,451 | |
| 2 | LQDA |
Liquidia Corp
|
110,628 | $8,820,370 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
233,191 | $8,084,731 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
310,453 | $7,640,248 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
349,439 | $6,275,924 | |
| 6 | PRGO |
PERRIGO Co plc
|
542,952 | $5,641,271 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
56,093 | $4,643,378 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
447,858 | $3,753,050 |
All Filings in XERS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,685,774 | 339,113 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,832,658 | 833,217 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,676,610 | 213,581 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,867,478 | 229,420 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||